Comparison of analytical approaches for liquid chromatography/mass spectrometry determination of the alcohol biomarker ethyl glucuronide in urine

Rapid Communications in Mass Spectrometry

Volumn 24, Issue 12, 2010, Pages 1737-1743

  Helander, Anders ^a   Kenan, Naama ^a   Beck, Olof ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMARKERS; BODY FLUIDS; IONIZATION OF LIQUIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHASE SEPARATION; SULFUR COMPOUNDS;

ANALYTICAL APPROACH; ANALYTICAL METHOD; BIOLOGICAL MATRIXES; ETHYL GLUCURONIDE; ETHYL SULFATE; EUROPEAN UNION DIRECTIVE; LC-MS-MS; LIQUID CHROMATOGRAPHY - MASS SPECTROMETRIES; REFERENCE METHOD; SOLID-PHASE EXTRACTION;

DIRECT INJECTION;

EID: 77953179818     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.4573     Document Type: Article

References (47)

1. Maurer HH. Clin. Chem. Lab. Med. 2004; 42: 1310.
2. Rivier L. Anal. Chim. Acta 2003; 492: 69.
3. Maurer HH. Anal. Bioanal. Chem. 2007; 388: 1315. Copyright # 2010 John Wiley & Sons, Ltd.LC/MS analytical approaches for urinaryethyl glucuronide 1743
4. European Commission Decision 2002/657/EC. Off. J. Eur. Commun. 2002; L221: 8.
5. World Anti-Doping Agency. The World Anti-Doping Code.International Standard for Laboratories. 2004; version 4.0.
6. SOFT/AAFS. Forensic Toxicology Laboratory Guidelines, 2006
7. Penders J, Verstraete A. Accred. Qual. Assur. 2006; 11: 284.
8. Bush DM. Forensic Sci. Int. 2008; 174: 111.
9. Maralikova B, Weinmann W. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004; 811: 21.
10. Kaufmann A, Butcher P, Maden K, Widmer M, Giles K, Uria D. Rapid Commun. Mass Spectrom. 2009; 23: 985.
11. Schurmann A, Dvorak V, Cruzer C, Butcher P, Kaufmann A. Rapid Commun. Mass Spectrom. 2009; 23: 1196.
12. Fox EJ, Twigger S, Allen KR. Ann. Clin. Biochem. 2009; 46: 50.
13. Pistos C, Karampela S, Papoutsis I, Athanaselis S, Spilio-poulou C, Maravelias C. Rapid Commun. Mass Spectrom. 2009;.23: 3772
14. Schmitt G, Aderjan R, Keller T, Wu M. J. Anal. Toxicol. 1995; 19: 91.
15. Palmer RB. Semin. Diagn. Pathol. 2009; 26: 18.
16. Helander A. J. Neural Transm. Suppl. 2003; 15.
17. Erim Y, Bottcher M, Dahmen U, Beck O, Broelsch CE, Helander A. Liver Transpl. 2007; 13: 757.
18. Hoiseth G, Karinen R, Christophersen AS, Olsen L, Normann PT, Morland J. Forensic Sci. Int. 2007; 165: 41.
19. Dahl H, Stephanson N, Beck O, Helander A. J. Anal. Toxicol. 2002; 26: 201.
20. Foti RS, Fisher MB. Forensic Sci. Int. 2005; 153: 109.
21. Hoiseth G, Bernard JP, Karinen R, Johnsen L, Helander A, Christophersen AS, Morland J. Forensic Sci. Int. 2007; 172: 119.
22. Halter CC, Dresen S, Auwaerter V, Wurst FM, Weinmann W. Int. J. Legal Med. 2008; 122: 123.
23. Helander A, Bottcher M, Fehr C, Dahmen N, Beck O. AlcoholAlcohol. 2009; 44: 55.
24. Helander A, Olsson I, Dahl H. Clin. Chem. 2007; 53: 1855.
25. Helander A, Dahl H. Clin. Chem. 2005; 51: 1728.
26. Costantino A, Digregorio EJ, Korn W, Spayd S, Rieders F. J. Anal. Toxicol. 2006; 30: 659.
27. Rohrig TP, Huber C, Goodson L, Ross W. J. Anal. Toxicol. 2006; 30: 703.
28. Rosano TG, Lin J. J. Anal. Toxicol. 2008; 32: 594.
29. Stephanson N, Dahl H, Helander A, Beck O. Ther. Drug Monit. 2002; 24: 645.
30. Weinmann W, Schaefer P, Thierauf A, Schreiber A, Wurst FM. J. Am. Soc. Mass Spectrom. 2004; 15: 188.
31. Bottcher M, Beck O, Helander A. Alcohol Alcohol. 2008; 43: 46.
32. Helander A, Beck O. Clin. Chem. 2004; 50: 936.
33. Helander A, Beck O. J. Anal. Toxicol. 2005; 29: 270.
34. Zheng Y, Helander A. J. Anal. Toxicol. 2008; 39: 778.
35. Bendroth P, Kronstrand R, Helander A, Greby J, Stephanson N, Krantz P. Forensic Sci. Int. 2008; 176: 76.
36. Gustavsson E, Andersson M, Stephanson N, Beck O. J. Mass Spectrom. 2007; 42: 881.
37. Bjornstad K, Beck O, Helander A. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009; 877: 1162.
38. Annesley TM. Clin. Chem. 2003; 49: 1041.
39. Gosetti F, Mazzucco E, Zampieri D, Gennaro MC. J. Chromatogr. A 2009. DOI: 10.1016/j.chroma.2009.11.060.
40. Wang S, Cyronak M, Yang E. J. Pharm. Biomed. Anal. 2007; 43: 701.
41. Politi L, Morini L, Groppi A, Poloni V, Pozzi F, Polettini A. Rapid Commun. Mass Spectrom. 2005; 19: 1321.
42. Bicker W, Lammerhofer M, Keller T, Schuhmacher R, Krska R, Lindner W. Anal. Chem. 2006; 78: 5884.
43. Freire IA, Barrera AM, Silva PC, Duque MJ, Gomez PF, Eijo PL. J. Appl. Toxicol. 2008; 28: 773.
44. Thierauf A, Halter CC, Rana S, Auwaerter V, Wohlfarth A, Wurst FM, Weinmann W. Addiction 2009; 104: 2007.
45. Helander A, Hagelberg CA, Beck O, Petrini B. Forensic Sci. Int. 2009; 189: e45.
46. Bergstrom J, Helander A, Jones AW. Forensic Sci. Int. 2003; 133: 86.
47. Substance Abuse and Mental Health Services Administration. Mandatory guidelines for federal workplace drug testing programs. Federal Register 2004; 69: 19644.